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ATM kinaseThe cellular protein hypoxia-inducible factor 1 alpha (HIF-1α) was induced after infection of human
ﬁbroblasts with human cytomegalovirus (HCMV). HCMV irradiated with ultraviolet light (uv-HCMV) also
elicited the effect, demonstrating that the response was provoked by interaction of the infecting virion with
the cell and that viral gene expression was not required. Although induction of HIF-1α was initiated by an
early event, accumulation of the protein was not detected until 9 hours post infection, with levels increasing
thereafter. Infection with uv-HCMV resulted in increased abundance of HIF-1α-speciﬁc RNA, indicating
stimulation of transcription. In addition, greater phosphorylation of the protein kinase Akt was observed, and
the activity of this enzyme was required for induction of HIF-1α to occur. HIF-1α controls the expression of
many cellular gene products; therefore the ﬁndings reveal new ways in which interaction of the HCMV
particle with the host cell may cause signiﬁcant alterations to cellular physiology.(C.M. Preston).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The herpesvirus human cytomegalovirus (HCMV), a member of the
subfamily Betaherpesvirinae, is an important human pathogen with
potentially severe effects in newborn infants and immunocompromised
individuals. HCMV gene expression is characterized by the sequential
transcription of immediate early (IE), early and late genes over a period
of many days after the initial infection (Wathen and Stinski, 1982). The
HCMV genome encodes approximately 170 proteins, and 71 of these
have been identiﬁed as components of the virus particle (Dolan et al.,
2004; Varnum et al., 2004). The virion also contains cellular proteins,
and RNAs of viral and cellular origin (Bresnahan and Shenk, 2000;
Greijer et al., 2000; Varnum et al., 2004). Infection with this complex
virus results in major alterations to the host cell, including increases or
decreases in the abundance of individual cell transcripts and proteins
(Browne et al., 2001; Chan et al., 2008; Hertel and Mocarski, 2004;
Kenzelmann and Muhlemann, 2000; Stanton et al., 2007; Zhu et al.,
1998).
Many of the effects of HCMV on the host cell result from the actions
of virus-encoded gene products synthesized de novo, but the
interactions of the infecting virion with the host cell can also initiate
signiﬁcant changes to cellular gene expression. The best studied ofthese is the induction of innate immune responses, which occurs even
when viral gene expression is prevented by irradiation of virus with
ultraviolet (uv) light. These responses include activation of the
transcription factors NF-κB and interferon regulatory factor 3, which
individually and in cooperation stimulate the production of a range of
inﬂammatory cytokines, including type 1 interferons (Abate et al.,
2004; Boehme et al., 2006; Boehme et al., 2004; Browne et al., 2001;
DeFilippis et al., 2010; Juckem et al., 2008; Navarro et al., 1998;
Netterwald et al., 2004; Noyce et al., 2009; Paladino et al., 2006;
Preston et al., 2001; Rodriguez et al., 1987; Yurochko et al., 1995; Zhu
et al., 1997), albeit at relatively low levels (Rodriguez et al., 1987).
Other cell responses attributed to the initial interaction of the virus
particle with host cell include the induction of speciﬁc chromosome
breaks (Fortunato et al., 2000), activation of an angiogenic response in
endothelial cells (Bentz and Yurochko, 2008), and resistance to
apoptotic death of monocytes (Chan et al., 2010). Most of the effects of
incoming virions described to date occur very shortly after infection,
resulting either from engagement with cell receptors or a response to
virus components by various pattern-recognition sensors.
The ﬁndings described here characterize the induction of hypoxia-
induced factor 1 alpha (HIF-1α) after HCMV infection. Mammalian cells
are constantly exposed to varying oxygen levels, and they have evolved
mechanisms to ensure rapid adaptation to conditions of hypoxia. A
primary level of control is through the “master” transcription factor
hypoxia-inducible factor (HIF), which consists of a DNA-binding
element, HIF-1β (also named ARNT), and a regulatory component,
HIF-1α (Bruick, 2008; Semenza, 1998; Semenza, 2001; Walmsley et al.,
2007). The levels ofHIF-1α are tightly controlledby rapid turnover of the
protein, mediated by the E3 ubiquitin ligase von Hippel–Lindau factor
Fig. 1. Induction ofHIF-1α byHCMV. A.HFFF2monolayersweremock-infected (lane 1) or
infectedwith partially puriﬁedHCMV AD169 (AD, lane 2) or gradient puriﬁed virions (PV,
lane 3). Extracts were analyzed at 24 h pi for the presence of HIF-1α. B. HFFF2monolayers
weremock-infected (lane 1) or infectedwithHCMV (AD, lane 2) or uv-HCMV (uv, lane 3).
Extracts were analyzed at 24 h pi for the presence of HIF-1α or immediate early (IE)
proteins1 and2. C.HFFF2monolayerswere infectedwithuv-HCMV.At22 hpi, one setwas
untreated (lanes 1 to 4) and one set was treatedwith 200 μMdeferoxamine (DFO, lanes 5
to 8). After a further 2 h, cycloheximide (100 μg/ml) was added to all monolayers and
extracts were made immediately (lanes 1 and 5), or after 10 min (lanes 2 and 6), 30 min
(lanes 3 and 7) or 60 min (lanes 4 and 8). HIF-1α levels were analyzed. D. HFFF2
monolayers were infected with uv-HCMV and extracts were analyzed for the presence of
HIF-1α at various times. E. HFFF2monolayers were infectedwith uv-HCMV (lanes 1 to 3),
mock-infected (lanes 4 to 6) or infected with HCMV (lanes 7 to 9), with DF2 replenished
each day. Extracts were made at various times and analyzed for the presence of HIF-1α.
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to theactionof prolinehydroxylases that use oxygen, iron, ascorbate and
2-oxoglutarate as cofactors. This results in hydroxylation of two proline
residues of HIF-1α that target the protein for ubiquitylation by VHL and
subsequent proteolytic degradation. Proline hydroxylation slows when
oxygen levels fall, and as a consequence HIF-1α accumulates and
associates with HIF-1β to form an active HIF-1 complex that directs the
transcription of hypoxia-responsive genes. The products of these genes
coordinatelymediatemany changes including enhanced glucose uptake
and glycolysis, angiogenesis, and release of inﬂammatory cytokines,
each of which hasmajor effects on cell physiology that contribute to cell
survival in the hypoxic environment.
Induction of HIF-1α can occur through non-hypoxic mechanisms.
Degradation of HIF-1α by the proline hydroxylase/VHL pathway is
maximal at normal oxygen concentration; therefore an increase in
mRNA amount or translational efﬁciency results in a rise in HIF-1α
protein levels. This can be provoked by various stimuli including
oxidative stress, exposure to hormones, growth factors or cytokines,
and infection by pathogens (Dery et al., 2005; Hellwig-Burgel et al.,
2005; Qutub and Popel, 2008; Werth et al., 2010; Zinkernagel et al.,
2007). A variety of signaling cascades activate transcription of theHIF1-
α gene, but stimulation of translation, when it occurs, depends on the
pathway controlled by the protein kinases phosphoinositide-3-kinase
(PI3K), Akt (also named protein kinase B) and mammalian target of
rapamycin (mTOR) (Fukuda et al., 2002; Hellwig-Burgel et al., 2005;
Laughner et al., 2001; Page et al., 2002). This is a well characterized
cascade that, in general terms, promotes cell survival in response to
external stimuli [reviewed by (Alessi and Cohen, 1998; Bahaskar and
Hay, 2007; Bai and Jiang, 2010; Engelmanet al., 2006; ShawandCantley,
2006)]. PI3K phosphorylates membrane phospholipids, and the pro-
ducts of the reaction, phosphatidylinositide di- and triphosphates, act
as second messengers that permit phosphorylation of Akt at threonine
308 (T308) by 3-phosphoinositide kinase 1 (PDK1), inducing a con-
formational change that allows subsequent full activation through
phosphorylation of Akt serine residue 473 (S473). Activated Akt exerts
numerous effects on cells of which one, phosphorylation of mTOR,
results in increased translation ofmanymRNAs including that encoding
HIF-1α. Recently, it has become apparent that Akt can be activated by
enzymes classed as PI3K-related kinases (PIKKs), suggesting alternative
mechanisms for integrating stimuliwith cellular changes (Boehmeet al.,
2008; Bozulic and Hemmings, 2009; Bozulic et al., 2008). The PIKKs
include ataxia telangiectasia-mutated kinase (ATM), ATMandRad3-like
kinase, and DNA-dependent protein kinase catalytic subunit (DNA-
PKcs), and theseenzymes coordinate the initial cellular response toDNA
damage. There is a direct evidence that DNA-PKcs can activate Akt by
catalyzing phosphorylation at S473 (Feng et al., 2004).
There are few studies that address the effects of viruses on HIF-1α.
Infectionwith respiratory syncytial virus or hepatitis C virus results in an
increase in HIF-1α levels that is attributed to stabilization of the protein
(Kilani et al., 2004; Nasimuzzaman et al., 2007; Ripoli et al., 2010).
Similarly, greater amounts of HIF-1α were detected after expression
of hepatitis B virus protein X or hepatitis E virus ORF3 protein, due
predominantly to reduced turnover (Moin et al., 2009; Yoo et al., 2003).
The human immunodeﬁciency virus 1 protein Vpr activates transcrip-
tion of HIF-1α (Deshmane et al., 2009). Increased HIF-1α expression
was observed in biopsies of skin tissues infectedwith the herpesviruses
varicella-zoster virus or Kaposi's sarcoma-associated herpesvirus
(KSHV) (Werth et al., 2010), and KSHV latency-associated nuclear
antigen (LANA)mediated transcriptional activation of HIF-1α (Cai et al.,
2006). In the case of KSHV, induction is linked to a positive feedback
loop, since HIF-1α cooperates with LANA to stimulate expression of the
viral RTA transcriptional activator during hypoxia-induced reactivation
(Cai et al., 2006). The Epstein–Barr virus latent membrane protein 1
(LMP1) enhances HIF-1α expression at the translational level, as a
consequence of LMP1-induced oxidative stress (Wakisaka et al., 2004).
There are no reports describing HIF-1α levels in HCMV-infected cells.Results
In initial experiments, extracts of HFFF2 cells were analyzed for the
presence of HIF-1α. At 24 h post infection (pi) with HCMV strain
AD169, using virus either partially puriﬁed by centrifugation of
medium harvested from infected cells or virions banded by centrifu-
gation. A signiﬁcant increase inHIF-1α levelswas found in cells infected
with either virus preparation (Fig. 1A). The requirement for viral gene
expression was investigated by irradiation of the virus stock with
ultraviolet (uv) light, using a dose that abolished detectable IE gene
expression at 24 h pi (Fig. 1B). HCMV that was irradiated (uv-HCMV)
was able to provoke the increase in HIF-1α levels, typically more
effectively than unirradiated virus (Fig. 1B, lanes 2 and 3). This
observation suggests that the increased amount of HIF-1α is a response
to the input virus rather than to viral products synthesized after
infection. In view of the fact that HIF-1α levels during hypoxia are
Fig. 2. Effect of IFN-β on induction of HIF-1α. A. HFFF2 monolayers were infected with
uv-HCMV. At 24 h pi, the culture medium was harvested, centrifuged at 13,000g for
2 min, and the supernatant was added to fresh HFFF2 monolayers, together with anti-
IFN-β antibody. The amount of antibody added was none (lane 1), 45 units (lane 2),
150 units (lane 3), 450 units (lane 4) or 1500 units (lane 5). Medium from uninfected
cells was also tested (lane 6). After incubation for 24 h, extracts were analyzed for the
presence of ISG15. B. HFFF2 monolayers were mock-infected (lane 1) or infected with
uv-HCMV. Either no antibody (lane 2) or 450 units of anti-IFN-β antibody (lane 3) was
added at 1 h pi. Extracts were made at 24 h pi and analyzed for the presence of HIF-1α.
C. HFFF2 monolayers were mock-infected (lane 1), infected with uv-HCMV (lane 2),
incubated with medium from mock-infected HFFF2 cells (lane 3), incubated with
medium from uv-HCMV-infected HFFF2 cells (lane 4), or incubated with medium from
uv-HCMV-infected HFFF2 cells plus 450 units of anti-IFN-β antiserum (lane 5). After
24 h, extracts were made and analyzed for the presence of HIF-1α and ISG15.
Table 1
Quantiﬁcation of HIF-1α-speciﬁc RNA.
Infection Relative HIF-1α-speciﬁc RNA
uv-HCMV, 7 h pi 1.9 (0.11)
uv-HCMV, 24 h pi 10.2 (1.82)
HCMV, 7 h pi 1.5 (0.10)
HCMV, 24 h pi 3.5 (0.58)
HFFF2 monolayers were mock-infected or infected with uv-HCMV or unirradiated
HCMV. RNA was prepared at 7 h and 24 h pi and analyzed by qRT-PCR. The amount of
HIF-1α-speciﬁc RNA compared to the value frommock-infected cells is presented, after
normalization to the levels of β-actin-speciﬁc RNA. The mean values from three
experiments are presented, with standard errors in brackets.
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stability of HIF-1α in uv-HCMV-infected cells was investigated.
Cycloheximide was added to cultures at 24 h pi, to inhibit synthesis of
the protein, and sampleswere analyzed at various times (Fig. 1C, lanes 1
to 4). As a control, infected cellswere treatedwith deferoxamine, which
stabilizes HIF-1α due to chelation of iron, for 2 h prior to and during
analysis of protein stability (Fig. 1C, lanes 5 to 8). HIF-1α in uv-HCMV-
infected cells was degraded with a half life of less than 10 min,
comparable to that reported for the protein in other cell types (Frede et
al., 2006; Laughner et al., 2001; Shin et al., 2008), whereas it was more
stable in deferoxamine-treated cells, as expected. The increased HIF-1α
level in uv-HCMV-infected cells was therefore not due to stabilization of
the protein. Since the response did not require viral gene expression and
was therefore initiated early in infection, the timing of HIF-1α induction
was investigated (Fig. 1D). Surprisingly, an increase in the HIF-1α level
was not detected until 9 h pi, afterwhich time the amount of the protein
continued to rise until 24 h pi. Continuing incubation for longer times
revealed that HIF-1α levels were greater than those in control cells at
48 h and72 hpi, irrespective ofwhether theviruswasuv-irradiated, but
that the degree of induction declined with time (Fig. 1E).
The delayed appearance of HIF-1α until 9 h pi suggested that it
was induced through an indirect process rather than as a response to
the initial attachment or entry of the virus particle, and therefore the
possible involvement of interferon beta (IFN-β), which is known to be
induced and released into the cell culture medium after infection with
uv-HCMV, was investigated (Fig. 2). The efﬁcacy of a commercially
available anti-IFN-β antibody was tested by adding various amounts
to supernatant from uv-HCMV-infected HFFF2 cells, then applying
this to fresh cells and analyzing interferon-stimulated gene 15 protein
(ISG15) levels after incubation for a further 24 h (Fig. 2A). Addition of
450 units of antibody to 0.5 ml of supernatant completely eliminated
production of ISG15. This quantity of antibody, when added to cultures
infected with uv-HCMV, did not prevent the induction of HIF-1α,
although the extent of the response was decreased by approximately
two-fold (Fig. 2B). In addition, incubation of HFFF2 cultures with
medium taken from uv-HCMV-infected monolayers resulted in only a
marginal induction of HIF-1α after 24 h, and this effect was neutralized
by anti-IFN-β serum (Fig. 2C). The experiments shown in Fig. 2
demonstrate that neither IFN-β produced in response to uv-HCMV,
nor any other factor released into culture medium, made a major con-
tribution to the induction of HIF-1α.
Previous studies have demonstrated that non-hypoxic signals can
induce HIF-1α by increasing the level of the cognate mRNA and/or
stimulating translation via the PI3K/Akt/mTOR signaling pathway
(Laughner et al., 2001; Page et al., 2002). The amount of HIF-1α-
speciﬁc RNA was analyzed by quantitative reverse transcriptase
polymerase chain reaction (qRT-PCR), taking samples at 7 h and 24 h
after infectionwith uv-HCMVor unirradiated virus (Table 1). At 7 h pi,
a small increase (1.9-fold) was observed in samples from uv-HCMV-
treated cultures, but at 24 h pi this rose to 10.2-fold. In samples from
cells infected with unirradiated HCMV, there was no signiﬁcant
change at 7 h pi and a 3.5-fold increase at 24 h pi. These results
demonstrate that induction of HIF-1α-speciﬁc RNA contributes to the
greater protein levels observed at 24 h pi. The lesser effect of
unirradiated virus is compatible with the lower amounts of HIF-1α
accumulated and suggests that virus-speciﬁed products made after
infection control the magnitude of the response, as found for the
induction of IFN-β (Browne et al., 2001; Taylor and Bresnahan, 2005).
The possibility that induction of HIF-1α required the pathway
initiated by activation of PI3K was investigated. HFFF2 monolayers
were mock infected or infected with uv-HCMV, and phosphorylation
of Akt was monitored by probing samples with an antibody speciﬁc
for the presence of phosphoserine at S473, in conjunction with an
antibody that recognized total Akt (Fig. 3A). An increase in
phosphorylation, relative to the total amount of Akt, was ﬁrst detected
at 9 h pi, with the extent of modiﬁcation greater at 13 h and 24 h pi.This time coursemirrors the induction ofHIF-1α (Fig. 1D). The effect of
the compound LY294002, a general inhibitor of PI3K andPIKKs (Knight
et al., 2006), was tested. Accumulation of HIF-1αwas severely reduced
when the compoundwas added at the low concentration of 10 μM1 h
after infection with uv-HCMV (Fig. 3B). The stimulation of Akt
phosphorylation at S473 in samples from cultures infected with uv-
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abolished by the presence of LY294002. The results in Fig. 3A and B
therefore demonstrate that infection with uv-HCMV results in
activation of Akt, and that this is important for the induction of HIF-1α.
The effect of inhibitor KU55933, which is highly speciﬁc for ATM
kinase (Hickson et al., 2004), was also investigated (Fig. 3C). Addition
of this compound at 1 μMand 3 μM resulted in increasing inhibition of
HIF-1α accumulation (Fig. 3C, lanes 3 and 4). Phosphorylation of Akt
at S473 was also reduced over the same concentration range. This
ﬁnding raised the possibility that ATM, a PIKK that is distinct from
PI3K, transmits a signal initiated by infection with uv-HCMV.
Phosphorylation of T308 is also an important step in the activation
of Akt, therefore the status of this residue was examined (Fig. 3D).
Infection with uv-HCMV resulted in increased phosphorylation atT308 (Fig. 3D, lanes 2 and 3), and this response was inhibited by
LY294002 (Fig. 3D, lane 4) andKU55933 (Fig. 3D, lane 1). To ensure that
the inhibitors LY294002 and KU55933 were acting as expected, their
effects on induction of Akt phosphorylation in response to insulin-like
growth factor 1 (IGF-1)were tested, since it is well established that IGF-
1 is an effector of Akt phosphorylation through the activities of PI3K and
PDK1 (Alessi and Cohen, 1998) (Fig. 3E and F). Phosphorylation of Akt
at S473 was detected 2 h after addition of 50 nM IGF-1 (Fig. 3E, lane 3),
and was inhibited by 10 μM LY294002 (Fig. 3E, lane 4) but not by 3 μM
KU55933 (Fig. 3E, lane 1), demonstrating that the latter compound did
not affect the pathway initiated through PI3K. Equivalent results were
obtained by analysis of phosphorylation of Akt at T308 (Fig. 3F).
Addition of IGF-1 did not elevate HIF-1α levels at either 2 h or 24 h after
addition to HFFF2 cells (results not shown).
Further tests to address the speciﬁcity of inhibition by LY294002 and
KU55933 were carried out. The compounds did not affect production of
ISG15 after infection with uv-HCMV (Fig. 3G). In addition, induction of
virus-encoded ICP36, an early protein that is synthesized with a time
course similar to that of HIF-1α, was not greatly altered after infection
with unirradiated HCMV (Fig. 3H). The latter control is relevant, since a
number of other compounds that we tested (PI3K inhibitors
wortmannin, PI-103, PI3K inhibitor VII and Akt inhibitors IV, VIII and
X) blocked HIF-1α induction but also severely reduced ICP36 synthesis,
suggesting that they caused additional nonspeciﬁc or indirect effects
(results not shown).
It was somewhat surprising that induction of HIF-1α had not been
reported previously, and one possible reason derives from the fact that
the experiments described here were carried out with fetal calf serum
present in the culture medium throughout the experiments, whereas
many studies on activation of signaling pathways by HCMV have
utilized cells that were serum-starved prior to and after infection. The
possible inﬂuence of serum concentration was therefore investigated
(Fig. 4). Induction of HIF-1αwas not detectable when fetal calf serum
was absent frommedium added after virus adsorption (Fig. 4A, lanes 1
and 2), although a full response occurred when the serum concentra-
tion was 1% or greater (Fig. 4A, lanes 5 and 6). Increased phospho-
rylation of Akt at S473 was observed at all serum concentrations, but
the absolute levels of phosphorylated protein were greater as the
serum level increased to 1%. Synthesis of ISG15 (Fig. 4B), or ICP36 after
infection with unirradiated virus (Fig. 4C), was similar whether the
culture medium had no serum or 5% serum.
The observation of S473 phosphorylation at 24 h pi, irrespective of
the presence of serum, is in apparent contrast with a previous report
in which no change in Akt phosphorylation at this residue was
detected after at 24 h after infection with uv-HCMV (Johnson et al.,Fig. 3. Effect of LY294002andKU55933on inductionofHIF-1α. A.HFFF2monolayerswere
mock-infected (M) or infected with uv-HCMV (I), and samples were analyzed at various
times for the presence of Akt phosphorylated at S473 (pAktS473) or for total Akt (Akt).
B. HFFF2 monolayers were mock-infected (M, lanes 1 and 3) or infected with uv-HCMV
(I, lanes 2 and 4). LY294002 (10 μM)was added at 1 h pi, and extracts weremade at 24 h
pi. Extracts were analyzed for the presence of HIF-1α, Akt phosphorylated at S473 or for
total Akt. C. HFFF2 monolayers were mock-infected (lane 1) or infected with uv-HCMV
(lanes 2 to 4). KU55933was added at 1 μM (lane 3) or 3 μM (lane 4) at 1 h pi and extracts
weremadeat24 hpi. Extractswere analyzed forHIF-1α, Akt phosphorylatedat S473or for
total Akt. D. HFFF2 monolayers were mock-infected (lane 2) or infected with uv-HCMV
anduntreated (lane 3)or treatedwith 3 μMKU55933 (lane 1) or 10 μMLY294002 (lane 4)
at 1 h pi. Extracts were made at 24 h pi and analyzed for Akt phosphorylated at T308
(pAktT308) or for total Akt. E. HFFF2monolayerswere untreated (lane 2) or preincubated
for 2 hwith3 μMKU55933 (lane 1), noadditions (lane3)or10 μMLY294002 (lane4). IGF-
1 (50 nM)was added and incubation continued for a further 2 h. Extracts weremade and
analyzed for Akt phosphorylated at S473or for total Akt. F. HFFF2monolayerswere treated
as described in the legend to E and extracts were analyzed for Akt phosphorylated at T308
or for total Akt. G. HFFF2 monolayers were mock-infected (lane 2) or infected with uv-
HCMV and untreated (lane 3) or treated with 3 μMKU55933 (lane 1) or 10 μM Ly294002
(lane 4) at 1 h pi. Extracts were made at 24 h pi and analyzed for the presence of HIF-1α
and ISG15. H. HFFF2monolayers weremock-infected (lane 2) or infectedwith HCMV and
untreated (lane 3) or treated with 3 μM KU55933 (lane 1) or 10 μM LY294002 (lane 4).
Extracts were made at 24 h pi and analyzed for the presence of HIF-1α and ICP36.
Fig. 4. Effect of serum concentration and rapamycin on induction of HIF-1α. A. HFFF2
monolayers were mock-infected (odd numbered lanes) or infected with uv-HCMV
(even numbered lanes). After adsorption of virus for 1 h, monolayers were washed
twice with serum-free medium and overlaid with medium containing the indicated
concentrations of fetal calf serum. Extracts were made at 24 h pi and analyzed for the
presence of HIF-1α, Akt phosphorylated at S473 (pAkt), or total Akt (Akt). B. HFFF2
cultures were infected with uv-HCMV (lanes 1 and 2) or mock-infected (lanes 3 and 4).
After adsorption of virus for 1 h, monolayers were washed twice with serum-free
medium and overlaid with medium containing 5% serum (lanes 1 and 3) or no serum
(lanes 2 and 4). Extracts were made at 24 h pi and analyzed for the presence of HIF-1α
and ISG15. C. HFFF2 monolayers were mock-infected (lane 1) or infected with HCMV
(lanes 2 and 3). After adsorption of virus for 1 h, monolayers were washed twice with
serum-free medium and overlaid with medium containing 5% serum (lanes 1 and 2) or
no serum (lane 3). Extracts were made at 24 h pi and analyzed for the presence of HIF-
1α and ICP36. D. Monolayers of HFFF2 (lanes 1 to 6) or HFL (lanes 7 to 12) cells were
mock-infected (M) or infected with uv-irradiated HCMV strain AD169 (A) or Towne
(T). After adsorption of virus for 1 h, monolayers were washed twice with serum-free
medium and overlaid with medium containing 5% serum (lanes 1 to 3 and 7 to 9) or no
serum (lanes 4 to 6 and 10 to 12). Extracts were made at 24 h pi and analyzed for the
presence of HIF-1α, Akt phosphorylated at S473 (pAkt), or for total Akt (Akt).
Table 2
Effect of inhibitors on HIF-1α-speciﬁc RNA accumulation.
Treatment Relative HIF-1α-speciﬁc RNA
uv-HCMV 8.6 (7.1, 10.1)
uv-HCMV+KU55933 10.8 (10.7, 10.9)
uv-HCMV+LY294002 4.8 (5.0, 4.5)
uv-HCMV, no serum 3.7 (4.5, 2.8)
HFFF2 cells were mock-infected or infected with uv-HCMV. At 1 h pi, no additions, 3 μM
KU55933, 10 μM LY294002, or serum-free medium (after two washes) were added.
RNA was prepared at 24 h pi and analyzed for the presence of HIF-1α-speciﬁc RNA. The
amount of HIF-1α-speciﬁc RNA compared to the value from mock-infected cells is
presented, after normalization to the levels of β-actin-speciﬁc RNA. The means of two
experiments are presented, with the individual determinations in brackets.
87S. McFarlane et al. / Virology 414 (2011) 83–902001). The protocol used by Johnson et al. (2001) differs from that used
in the experiments reported here in a number of respects. The previous
study used cells that were serum-starved for 48 h prior to and after
infection, and in addition the cell type (human embryonic lung
ﬁbroblasts) and HCMV strain (Towne) were different. Induction of
HIF-1α and S473 phosphorylation were compared in human fetal
foreskin and fetal lung ﬁbroblasts, after infection with uv-irradiated
HCMV AD169 or Towne strains (Fig. 4D). In foreskin ﬁbroblasts,
infection with either AD169 (A) or Towne (T) induced HIF-1α in the
presence, but not the absence, of serum added after adsorption, and Akt
phosphorylation occurred irrespective of the presence of serum(Fig. 4D,
lanes 1 to 6). Similarly, HIF-1αwas induced by both virus strains in thepresence of serum in lung ﬁbroblasts, and S473 phosphorylation
occurred after infection with either virus strain (Fig. 4D, lanes 7 to 12).
In relative terms, however, the degrees of HIF-1α induction and Akt
phosphorylation were lower in lung ﬁbroblasts.
HIF-1α-speciﬁc RNA levels were determined by qRT-PCR at 24 h pi
in cultures treated with LY294002, KU55933 or medium without
serum (Table 2). KU55933 had no effect, whereas LY294002 and
absence of serum reduced the stimulation by uv-HCMV from 8.6-fold
to 4.8- and 3.5-fold, respectively.Discussion
The results presented here reveal a new aspect of interaction of
HCMV with the host cell. The “master” transcription factor HIF was
induced upon infection with HCMV, and the response was greater
when the virus was irradiated with a dose of uv light sufﬁcient to
prevent detectable viral gene expression, indicating that components
of the initial infecting virion are responsible. It is surprising that the
interaction of virus particle with the host cell can provoke a response
that is delayed to such an extent, since by 9 h pi at the relatively high
MOI of 3 the viral transcription program had progressed through the
stages at which the genome reaches the nucleus, is uncoated and
becomes available for transcription. Indeed, observing the time course
of HIF-1α induction in isolation would favor the conclusion that viral
IE, or even early, proteins playmajor roles in the response. Presumably
the initial events in infection trigger a series of cellular changes that
culminate in the production of HIF-1α.
Two elements of the response to HCMV are necessary for induction
ofHIF-1α, neither ofwhich is sufﬁcient alone. Increased transcription, or
an effect on processing of the primary transcript, is required in
combinationwith themaintenance of Akt phosphorylation. The cellular
factor NF-κB, when activated, strongly stimulates HIF-1α transcription
(Frede et al., 2006; Rius et al., 2008; van Uden et al., 2008). Activation
and increases in the amount of this factor also occur after HCMV
infection, and these events are important for the efﬁcient transcription
of IE genes (Caposio et al., 2004; DeMeritt et al., 2004; Kowalik et al.,
1993; Sambucetti et al., 1989; Yurochko et al., 1995). It is possible,
therefore, that utilization of NF-κB for viral IE transcription brings the
additional consequence of HIF-1α induction.
It is not clear from our data whether the uv-HCMV-mediated
stimulation of Akt phosphorylation is vital for the induction of HIF-1α,
or if the constitutive activity of the enzyme sufﬁces. Nonetheless, the
ﬁnding that increased Akt phosphorylation coincides with HIF-1α
induction after infection with uv-HCMV highlights a delayed response
to the initial virus–cell interaction thatmayhaveprofoundeffects on cell
physiology, since Akt inﬂuences apoptosis, protein synthesis, cell
proliferation and glucose metabolism. Indeed, we have detected
increased phosphorylation of glycogen synthase kinase, a substrate of
Akt, at 24 h after infection with uv-HCMV (C.M. Preston, unpublished
observations). Activation of the PI3K/Akt pathway has been reported
previously (Johnson et al., 2001). That study demonstrated rapid
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subsided at 2 hpi and re-emerged from4 honwards after infectionwith
untreatedHCMV. The initial activationwasobserved after infectionwith
uv-HCMV but the second wave was not, in contrast to our ﬁnding that
Akt phosphorylation was increased by uv-HCMV at 9 h and 24 h pi.
We eliminated differences in virus strain as a signiﬁcant variable, and
observed Akt phosphorylation in lung ﬁbroblasts at 24 h pi, albeit at
lower efﬁciency than in foreskin cells. The other major experimental
difference between the studies is that Johnson et al. (2001) used cells
that were serum-starved for 48 h prior to infection and during the
experiment, whereas in our work serum was present throughout. We
have not tested cultures preincubated in serum-free medium, but we
found increased Akt phosphorylation at 24 h after infection with uv-
HCMV when serum was omitted from 1 h pi onwards (Fig. 4).
The inhibitory action of LY294002 merely indicates the involve-
ment of PI3K or a PIKK in induction of HIF-1α, since this inhibitor is
active againstmany classes of these enzymes (Knight et al., 2006). The
compound KU55933, however, is very speciﬁc for ATM protein kinase,
and its inhibitory effect strongly suggests a role for this enzyme in
activation of Akt and induction of HIF-1α. The ATM kinase is an early
sensor of DNA damage, localizing with DNA-PKcs to double strand
breaks and initiating responses that stall cell cycle progression and
enable repair of the lesion. It is conceivable that the two free ends of
the incoming HCMV genome mimic a DNA lesion which is recognized
by ATM. In turn, this may result in phosphorylation of Akt either
directly or, more likely, through the action of DNA-PKcs by in response
to phosphorylation by ATM (Chen et al., 2007). The ability of DNA-
PKcs to promote phosphorylation of Akt at both S473 and T308 in
response to damage has been described (Bozulic et al., 2008). In
preliminary experiments, we found that the DNA-PKcs inhibitor
NU7026 was almost as potent as KU55933 in inhibiting induction of
HIF-1α (C.M. Preston, unpublished observations). The possibility that
ATM or DNA-PKcs are involved in induction of HIF-1α receives
support from a study of the DNA damage response in HCMV-infected
ﬁbroblasts (Luo et al., 2007). Increased phosphorylation of Nijmegen
break syndrome protein (Nbs1), an ATM substrate, was detected from
4 h pi and maintained throughout infection, suggesting a role for ATM
at an early time. The usual relocalization of Nbs1 and most other
proteins associated with DNA repair to discrete foci was not observed,
however, leading to the conclusion that input viral DNA initiates some
aspects of a damage response but that the migration of the associated
proteins to the appropriate sites within the nucleus is inhibited (Luo
et al., 2007). This is compatible with the hypothesis that ATM
integrates a response to the viral genome via DNA-PKcs and activation
of Akt, leading to increased translation of HIF-1α mRNA.
Akt activation occurs in the absence of serumbut induction ofHIF-1α
does not, suggesting that the cell components responsive to serum act
downstream of Akt. Although there are many candidates, due to the
central role of Akt in cell proliferation, there is evidence from other
systems that mTOR is important for translation of HIF-1α mRNA
(Laughner et al., 2001; Page et al., 2002). Indeed, we have found that
rapamycin, which acts speciﬁcally on mTOR, strongly depresses HIF-1α
induction (M.J. Nicholl and C.M. Preston, unpublished observations).
AlthoughmTOR is stimulated by Akt, its activity is known to be reduced
by anumber of pathwayswhennutrients are limitedor cells are stressed,
therefore translation of HIF-1α mRNA may be inhibited in serum-free
conditionsbyoneormoremechanisms (Baiand Jiang, 2010;Hotamisligil
and Erbay, 2008; Li et al., 2003; Reiling and Sabatini, 2006). Speculation
on the possible signiﬁcance of mTOR in the requirement for serum is
complicated by the fact that HCMV infection alters the properties of
this enzyme. The substrate speciﬁcities and rapamycin sensitivities of
the mTOR-associated complexes mTORC1 and mTORC2 are altered by
a mechanism that is currently unclear (Kudchodkar et al., 2004;
Kudchodkar et al., 2006; Moorman and Shenk, 2010; Walsh et al.,
2005). In addition, a viral protein (UL38) interacts with the tuberous
sclerosis complex,which regulatesmTOR activity, to render it insensitiveto stress signals (Moorman et al., 2008). A hypothesis that links mTOR
with the requirement for serum inHIF-1α induction requires a resolution
ofwhether thedocumented changes in theproperties ofmTORalsooccur
after infection with uv-HCMV. Its absence in serum-free conditions
suggests that HIF-1α is not of major signiﬁcance for HCMV replication in
cultured ﬁbroblasts, because the omission of serum from medium only
marginally reduced virus yields (Kudchodkar et al., 2004). The existence
and signiﬁcance of the response in other cell types remain to be
elucidated.
The induction of HIF-1α has important effects on cell physiology,
since the protein stimulates expression of a plethora of cellular gene
products, including those involved in glucose uptake, glycolysis,
angiogenesis and inﬂammation. Future studies should investigate the
extent to which the infecting HCMV particle can provoke these HIF-1-
mediated changes. In humans, HCMV infects a range of cell types and in
many cases the outcome is latency or abortive infection. In these
situations, where productive virus replication does not ensue, it is
nonetheless possible that activation of Akt and induction ofHIF-1αhave
profound effects on the host cell, and analysis of these possibilities may
yield important new insights into HCMV pathogenesis.
Materials and methods
Cells, viruses and inhibitors
Human fetal foreskin ﬁbroblasts (HFFF2, European Collection of
Cell Cultures) and human fetal lung cells (HFL, ICN Flow) were
propagated in Dulbecco's modiﬁed Eagle medium supplemented with
5% v/v fetal calf serum, 5% v/v newborn calf serum, nonessential amino
acids, plus 100 units of penicillin and 100 μg of streptomycin per
milliliter (D5+5). After infection, Dulbecco's modiﬁed Eagle medium
supplemented with 2% v/v fetal calf serum, nonessential amino acids,
plus 100 units of penicillin and 100 μg of streptomycin per milliliter
was used. HCMV, strain AD169, was propagated in HFFF2 cells and
stocks were prepared by centrifugation of medium harvested from
infectedmonolayers,ﬁrst at 1000g for 15 min to remove cellular debris
followed by 23,000g for 2 h. Pellets from the latter centrifugationwere
resuspended in D5+5 and puriﬁed further by negative viscosity:
positive density gradient centrifugation (Talbot and Almeida, 1977).
The band identiﬁed as virionswas removed from the gradient, pelleted
by centrifugation at 23,000g for 2 h and resuspended in D5+5. HCMV
strain Towne, prepared from infected cell culture medium, was kindly
provided by Dr. D. Dargan (MRC—University of Glasgow Centre for
Virus Research, Glasgow, UK). HCMV was uv-irradiated in a strata-
linker (Stratagene), as described previously (Lukashchuk et al., 2008).
HFFF2monolayers, consisting of 1.5×105 cells, were routinely infected
with 3 pfu of HCMV per cell, or an equivalent amount of virus after uv-
irradiation. Cycloheximide, IGF-1 and deferoxamine mesylate were
obtained fromSigmaAldrich. LY294002, KU55933 and other inhibitors
were purchased from Calbiochem Merck.
Protein blotting
Cell extracts were prepared and analyzed by blotting as described
previously (Marshall et al., 2002). Human β-actin was used as a
loading control. Sources of primary antibodies were: Anti-HIF-1α, BD
Transduction Laboratories; anti-phosphoAkt (S473), anti-phosphoAkt
(T308), and anti-Akt, Cell Signaling Technology; anti-β-actin, Sigma
Aldrich; anti-ISG15, Santa Cruz; anti-HCMV ICP36, Abcam; anti-HCMV
IE1/IE2, AbD Serotec.
Quantitative reverse transcription and polymerase chain reaction
Total RNAwas isolated using RNA-Bee reagent (AMSBiotechnology)
according to the manufacturer's protocol, and quantiﬁed by uv
spectrometry. RNA was converted to complementary DNA using oligo
89S. McFarlane et al. / Virology 414 (2011) 83–90(dT) primers andMoloneymurine leukemia virus reverse transcriptase.
Quantitative polymerase chain reaction analysis was performed using
TaqMan probes for HIF-1α (Hs00936366, Applied Biosystems Inc.) and
β-actin (4333762, ABI). Reactions were performed under conditions
speciﬁed in the ABI TaqMan Universal Master Mix II protocol, on an ABI
7500 Real Time PCR machine. Data were quantiﬁed by the relative
standard curve method.Acknowledgment
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